NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (LIPOCALIN 2)
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- D-02B0021YH
- Basic UDI-DI Code
- B-02B0021YH
- Reference
- 2M001
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Changsha Sinocare Inc.
Additional Description
NGAL Reagent Kit is intended to quantitatively determine the content of NGAL in human plasma in vitro. Clinically, it is mainly used for the auxiliary diagnosis of early acute kidney injury (AKI). NGAL serves as a biomarker in renal injury and function at the early stage. When AKI is diagnosed in the early stage, the concentration of NGAL usually increases rapidly in blood and urine, which is the most obvious within 2 hours. It can be used to determine AKI in patients with ischemic renal injury, sepsis, heart surgery and the response of intravenous X-ray contrast agent.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0102060207 | NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN (LIPOCALIN 2) |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).